Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Queensland Health
Cerilliant
Express Scripts
Julphar
Fish and Richardson
AstraZeneca
McKesson

Generated: April 25, 2018

DrugPatentWatch Database Preview

OMNICEF Drug Profile

« Back to Dashboard

When do Omnicef patents expire, and when can generic versions of Omnicef launch?

Omnicef is a drug marketed by Abbvie and is included in two NDAs.

The generic ingredient in OMNICEF is cefdinir. There are twelve drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cefdinir profile page.
Drug patent expirations by year for OMNICEF
Synonyms for OMNICEF
(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime
(6R,7R,Z)-7-(2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-hydroxyimino-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-hydroxyimino-acetyl]amino]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-hydroxyimino-ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{2-(2-Amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(7R)-3-Vinyl-7-[[(2-amino-4-thiazolyl)[(E)-hydroxyimino]acetyl]amino]cepham-3-ene-4-carboxylic acid
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl) (hydroxyimino)acetyl)amino)-3-ethenyl-8-oxo-, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(hydroxyiminoacetyl)amino)-3-ethenyl-8-oxo-, (6R-(6-alpha,7-beta(Z)))-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)-
7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
832C405
91832-40-5
A844075
AB01274720_02
AB01274720_03
AB01274720-01
AB1009352
ABP000637
AC1OCD3C
AK162391
AKOS015951262
AN-15138
BCP9000503
BCPP000293
BIDD:GT0827
BMY 28488
BMY-28488
BRD-K15766189-001-05-6
BSPBio_002735
C08110
C14H13N5O5S2
CCG-39455
Cefdiel
cefdinir
Cefdinir (JP15/USAN/INN)
Cefdinir (JP17/USAN/INN)
Cefdinir (Omnicef)
Cefdinir [USAN:INN]
Cefdinir [USAN:USP:INN:BAN]
Cefdinir monohydrate
Cefdinir, 97%
Cefdinir, Antibiotic for Culture Media Use Only
Cefdinir(Omnicef)
Cefdinir(Omnicef)/
Cefdinirum
Cefdinirum [INN-Latin]
Cefdinyl
Cefdirnir
cefnil
Ceftinex
Cefzon
Cefzon (TN)
CFDN
CHEBI:3485
CHEMBL927
CI 983
CI-983
CI0FAO63WC
cid_6915944
CPD000469224
CS-1925
D00917
D0WS1X
DB00535
DTXSID8046084
FK 482
FK-482
FR-80482
HMS1922L19
HMS2093K20
HY-B0136
KS-1038
LS-149988
MFCD00865030
MLS001304703
MLS001424233
MolPort-002-885-812
NCGC00178499-01
NSC-758926
NSC758926
Omnicef (TN)
Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir
PD 134393
PD-134393
Pharmakon1600-01505208
PubChem13658
s1605
SAM001246818
SBI-0206739.P001
SC-17007
SCHEMBL36995
SPECTRUM1505208
Spectrum5_001560
SR-05000001991
SR-05000001991-2
ST24046294
syn-7-[2-(2-Amino-4-thiazolyl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid; [6R-[6|A-7|A(Z)]]-7-[[(2-Amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyl
UNII-CI0FAO63WC
X-2542
ZINC13119676

US Patents and Regulatory Information for OMNICEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie OMNICEF cefdinir CAPSULE;ORAL 050739-001 Dec 4, 1997 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-001 Dec 4, 1997 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-002 Jul 29, 2004 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for OMNICEF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-002 Jul 29, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie OMNICEF cefdinir CAPSULE;ORAL 050739-001 Dec 4, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie OMNICEF cefdinir FOR SUSPENSION;ORAL 050749-001 Dec 4, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Baxter
Cipla
Express Scripts
Medtronic
UBS
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.